Polomar Health ServicesPMHS 33 Days Payable is 101.16 as of Mar. 2026, which is 92% below its 10-year median of 1,329.64. GuruFocus rates PMHS with a GF Score™ of 33/100 and a GF Value™ of $12.34 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 608 Healthcare Providers & Services companies, Polomar Health Services ranks better than 82.89% on this metric.
The historical rank and industry rank for Polomar Health Services's Days Payable or its related term are showing as below:
PMHS'
s Days Payable Range Over the Past 10 Years
Min: 178.86 Med: 1329.64 Max: 2007.5
Current: 178.86
During the past 7 years, Polomar Health Services's highest Days Payable was 2007.50. The lowest was 178.86. And the median was 1329.64.
PMHS's Days Payable is ranked better than 82.89% of 608
companies
in the Healthcare Providers & Services industry
Industry Median: 58.08
vs PMHS: 178.86
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Polomar Health Services's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Polomar Health Services Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Polomar Health Services's Days Payable distribution charts can be found below:
* The bar in red indicates where Polomar Health Services's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Polomar Health Services's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Polomar Health Services (PMHS) has a Days Payable of 101.16 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Polomar Health Services and its competitors. This is 92% below median its historical median of 1,329.64. Over the past decade, Polomar Health Services' Days Payable has ranged from 178.86 to 2,007.50. According to the industry distribution chart, Polomar Health Services ranks #104 out of 608 companies in the Healthcare Providers & Services industry, placing it in the top 17.1%.
Is Polomar Health Services' Days Payable too high?
Polomar Health Services' current Days Payable of 101.16 is 92% below median its 10-year median of 1,329.64. Over the past 10 years, this metric has ranged from a low of 178.86 to a high of 2,007.50. The Healthcare Providers & Services industry median Days Payable is 58.08. Polomar Health Services' value of 101.16 is 74.2% above this industry median. Based on the distribution chart, Polomar Health Services ranks #104 out of 608 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Polomar Health Services has a GF Score™ of 33/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Polomar Health Services' Days Payable compare to RDGT and DHTI?
According to the Healthcare Providers & Services industry distribution chart, Polomar Health Services ranks #104 out of 608 companies for Days Payable. This places Polomar Health Services in the top 17% of its industry — outperforming the majority of peers. The industry median Days Payable is 58.08. Polomar Health Services' value of 101.16 is 74.2% above this benchmark. Historically, Polomar Health Services' own Days Payable has ranged from 178.86 to 2,007.50 over the past decade. While the company's 10-year median is 1,329.64 vs. the industry median of 58.08, Polomar Health Services has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.08, based on 608 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Polomar Health Services's current Days Payable of 101.16 is 74.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Polomar Health Services and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Polomar Health Services's current Days Payable is 101.16, which is 92% below median its own 10-year median of 1,329.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polomar Health Services stock overvalued right now?
Based on GuruFocus' analysis, Polomar Health Services (PMHS) is currently considered Possible Value Trap. The stock's GF Value™ is $12.34, compared to a current price of $0.12 — trading 99% below its estimated fair value. The current Days Payable is 101.16, which is 92% below median its 10-year median of 1,329.64 and 74.2% above the Healthcare Providers & Services industry median of 58.08. Polomar Health Services' overall GF Score™ is 33/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Polomar Health Services (PMHS), the current Days Payable is 101.16 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Polomar Health Services (PMHS) Overvalued in 2026?
Based on GuruFocus' analysis, Polomar Health Services stock appears to be undervalued.
The current stock price of $0.12 is trading 99% below its estimated GF Value™ of $12.34.
GuruFocus considers Polomar Health Services to be Possible Value Trap.
Key valuation signals for PMHS:
Days Payable: 101.16 (92% below median its 10-year median of 1,329.64)
GF Value™: $12.34 vs. price of $0.12 (99% below fair value)
Industry Position: 74.2% above the Healthcare Providers & Services median (#104 of 608)
No single metric tells the full story. See the PMHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Polomar Health Services Inc is a U.S.-based healthcare company specializing in retail compounding pharmacy services and prescription fulfillment for telehealth platforms. It is also licensed as a Special Sterile Compounding Pharmacy, permit #PH35277, which authorizes the licensed entity to dispense injectable and other sterile compounds (eye drops, infused therapeutics) upon receipt of a valid prescription. The firm is presently licensed and authorized to fulfill and deliver compounded prescribed medications in 28 states.
33GF Score
Get the complete analysis for PMHS
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PMHS has been successfully added to your 
